| Literature DB >> 33477867 |
Keiichiro Baba1, Masashi Mizumoto1, Yoshiko Oshiro1,2, Shosei Shimizu1, Masatoshi Nakamura1, Yuichi Hiroshima1, Takashi Iizumi1, Takashi Saito1, Haruko Numajiri1, Kei Nakai1, Hitoshi Ishikawa1,3, Toshiyuki Okumura1, Kazushi Maruo4, Hideyuki Sakurai1.
Abstract
Impairment of bone growth after radiotherapy for pediatric bone cancer is a well-known adverse event. However, there is limited understanding of the relationship between bone growth and irradiation dose. In this study, we retrospectively analyzed bone growth impairment after proton beam therapy for pediatric cancer. A total of 353 vertebral bodies in 23 patients under 12 years old who received proton beam therapy were evaluated. Compared to the non-irradiated vertebral body growth rate, the irradiated vertebral body rate (%/year) was significantly lower: 77.2%, 57.6%, 40.8%, 26.4%, and 14.1% at 10, 20, 30, 40, and 50 Gy (RBE) irradiation, respectively. In multivariate analysis, radiation dose was the only factor correlated with vertebral body growth. Age, gender, and vertebral body site were not significant factors. These results suggest that the growth rate of the vertebral body is dose-dependent and decreases even at a low irradiated dose. This is the first report to show that proton beam therapy has the same growth inhibitory effect as photon radiotherapy within the irradiated field.Entities:
Keywords: bone; child; pediatric; proton beam therapy; vertebral body
Year: 2021 PMID: 33477867 PMCID: PMC7832908 DOI: 10.3390/cancers13020349
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639